The role and therapeutic potential of macrophages in the pathogenesis of diabetic cardiomyopathy

被引:2
|
作者
Zhang, Shan [1 ]
Zhu, Xueying [2 ]
Chen, Yupeng [1 ]
Wen, Zhige [1 ]
Shi, Peiyu [1 ]
Ni, Qing [1 ]
机构
[1] Guanganmen Hosp, China Acad Chinese Med Sci, Dept Endocrinol, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Dept Anat, Beijing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
macrophages; diabetic cardiomyopathy; diabetes; inflammation; cardiovascular diseases; TUMOR-ASSOCIATED MACROPHAGES; MYOCARDIAL-INFARCTION; SGLT2; INHIBITION; CARDIAC-FUNCTION; M2; MACROPHAGES; RENAL INJURY; INFLAMMATION; MICE; PIOGLITAZONE; ATHEROSCLEROSIS;
D O I
10.3389/fimmu.2024.1393392
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review provides a comprehensive analysis of the critical role played by macrophages and their underlying mechanisms in the progression of diabetic cardiomyopathy (DCM). It begins by discussing the origins and diverse subtypes of macrophages, elucidating their spatial distribution and modes of intercellular communication, thereby emphasizing their significance in the pathogenesis of DCM. The review then delves into the intricate relationship between macrophages and the onset of DCM, particularly focusing on the epigenetic regulatory mechanisms employed by macrophages in the context of DCM condition. Additionally, the review discusses various therapeutic strategies aimed at targeting macrophages to manage DCM. It specifically highlights the potential of natural food components in alleviating diabetic microvascular complications and examines the modulatory effects of existing hypoglycemic drugs on macrophage activity. These findings, summarized in this review, not only provide fresh insights into the role of macrophages in diabetic microvascular complications but also offer valuable guidance for future therapeutic research and interventions in this field.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] THE ROLE OF RIBONUCLEASE A AS POTENTIAL NEW THERAPEUTIC IN SEPTIC CARDIOMYOPATHY
    Stiehler, Lara
    Riordan, Caroline O.
    Zechendorf, Elisabeth
    Coldewey, Sina
    Wissuwa, Bianka
    Dohmen, Fiona
    Hinkelmann, Daniel
    Ostareck-Lederer, Antje
    Ostareck, Dirk
    Marx, Gernot
    Thiemermann, Christoph
    Martin, Lukas
    SHOCK, 2019, 51 (06): : 83 - 84
  • [42] The Role of the Endothelium in HPS Pathogenesis and Potential Therapeutic Approaches
    Gavrilovskaya, Irina
    Gorbunova, Elena
    Matthys, Valery
    Dalrymple, Nadine
    Mackow, Erich
    ADVANCES IN VIROLOGY, 2012, 2012
  • [43] Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
    Ke, Xiangyu
    Lin, Zhirui
    Ye, Zebing
    Leng, Meifang
    Chen, Bo
    Jiang, Chunjie
    Jiang, Xiaoyun
    Li, Guowei
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [44] Pathophysiology, Clinical Characteristics of Diabetic Cardiomyopathy: Therapeutic Potential of Natural Polyphenols
    Atale, Neha
    Yadav, Dhananjay
    Rani, Vibha
    Jin, Jun-O
    FRONTIERS IN NUTRITION, 2020, 7
  • [45] Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
    Yi Tan
    Zhiguo Zhang
    Chao Zheng
    Kupper A. Wintergerst
    Bradley B. Keller
    Lu Cai
    Nature Reviews Cardiology, 2020, 17 : 585 - 607
  • [46] Targeting endoplasmic reticulum stress as a potential therapeutic strategy for diabetic cardiomyopathy
    Congur, Irem
    Mingrone, Geltrude
    Guan, Kaomei
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2025, 162
  • [47] Exercise as A Potential Therapeutic Target for Diabetic Cardiomyopathy: Insight into the Underlying Mechanisms
    Seo, Dae Yun
    Ko, Jeong Rim
    Jang, Jung Eun
    Kim, Tae Nyun
    Youm, Jae Boum
    Kwak, Hyo-Bum
    Bae, Jun Hyun
    Kim, Amy Hyein
    Ko, Kyung Soo
    Rhee, Byoung Doo
    Han, Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (24)
  • [48] Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
    Tan, Yi
    Zhang, Zhiguo
    Zheng, Chao
    Wintergerst, Kupper A.
    Keller, Bradley B.
    Cai, Lu
    NATURE REVIEWS CARDIOLOGY, 2020, 17 (09) : 585 - 607
  • [49] Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?
    Richard Van Krieken
    Joan C. Krepinsky
    Current Diabetes Reports, 2017, 17
  • [50] Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?
    Van Krieken, Richard
    Krepinsky, Joan C.
    CURRENT DIABETES REPORTS, 2017, 17 (03)